Status:
UNKNOWN
Evicel Study on the Peri-operative Bleeding in Total Knee Prothesis Surgery
Lead Sponsor:
Clinique Mutualiste Chirurgicale de la Loire
Conditions:
Thrombosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Knee prothesis surgery is responsible of a risk of thrombosis and hemorrhage. To prevent thrombosis, patients have systematic anticoagulation after surgery which are responsible of hemorrhage. A local...
Detailed Description
The orthopaedic surgeon administers a local pulverisation of the biological glue during the surgery.
Eligibility Criteria
Inclusion
- Patient affiliated with or a beneficiary of a social security category:
- having more than 18 years old
- having signed the informed consent form
- having undergone a total knee prosthesis surgery operation
Exclusion
- incapacity to understand the protocol
- patient having taken anti-coagulants or clopidogrel 10 days before excepted aspirin to a dose equal or less than 160 mg/day
- women having period so generally women having less than 50 years old
- PT less than 60% and ACT taller than 10 sec
- contra-indications to the drug
- Erytropoietine treatment required before surgery
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT00983112
Start Date
September 1 2009
End Date
December 1 2012
Last Update
April 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Saint-Etienne
Saint-Etienne, France, 42000